Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Amount Raised
$72 Million
Round Type
Series B
WatertownBiotechnologyHealthcareHealth CareTherapeuticsDescription
Werewolf Therapeutics, Inc., an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, today announced the completion of its $72 million Series B financing. The proceeds from the Series B financing will advance Werewolf's lead INDUKINE™ product candidates, WTX-124 (interleukin-2, or IL-2) and WTX-330 (interleukin-12, or IL-12) through Phase 1 clinical proof-of-concept studies, and progress additional programs to Investigational New Drug application-readiness. INDUKINE™ molecules are a novel class of systemically delivered, conditionally activated proinflammatory immune modulators.
Quick answer
Werewolf Therapeutics raised $72 Million in a Series B round, dated January 7, 2021. Werewolf Therapeutics is based in Watertown, Massachusetts, United States.
- How much did Werewolf Therapeutics raise?
- Werewolf Therapeutics raised $72 Million in a Series B round on January 7, 2021.
- What does Werewolf Therapeutics do?
- Werewolf Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
- Where is Werewolf Therapeutics based and how big is it?
- Werewolf Therapeutics is based in Watertown, Massachusetts, United States. Fundz records about 23 employees.
- Who are the decision-makers at Werewolf Therapeutics?
- Fundz holds 2 contacts at Werewolf Therapeutics, including the Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Werewolf Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Phio Pharmaceuticals raised $14M on February 16, 2021.
- Design Therapeutics, Inc. raised $125M on February 12, 2021.
- ISOThrive raised $5.2M on February 5, 2021.
- Design Therapeutics, Inc. raised $125M (Series B) on January 27, 2021.
- SAGE Therapeutics raised $650M on January 15, 2021.
- Zevra Therapeutics, Inc. raised $31M on January 13, 2021.
Who to call at Werewolf Therapeutics, and when
A new round usually means Werewolf Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Werewolf Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Werewolf Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Werewolf Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Werewolf Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWerewolf Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.